Skip to main content
. 2020 Jun 24;58(7):e00128-20. doi: 10.1128/JCM.00128-20

TABLE 6.

Qualitative BioFire PN panel performance for bacteria using qRefCx and SOC as comparators

Organism Specimena qRefCx (103.5 cutoff)
SOCb
Sensitivity
Specificity
Sensitivity
Specificity
TP/(TP+FN) % (95% CI) TN/(TN+FP) % (95% CI) TP/(TP+FN) % (95% CI) TN/(TN+FP) % (95% CI)
A. calcoaceticus-A. baumannii complex BAL 0/0 839/846 99.2 (98.3–99.6) 2/2 100 (34.2–100) 831/836 99.4 (98.6–99.7)
SPU 10/11 90.9 (62.3–98.4) 807/825 97.8 (96.6–98.6) 12/15 80.0 (54.8–93.0) 789/805 98.0 (96.8–98.8)
E. cloacae complex BAL 11/12 91.7 (64.6–98.5) 822/834 98.6 (97.5–99.2) 15/17 88.2 (65.7–96.7) 813/821 99.0 (98.1–99.5)
SPU 11/12 91.7 (64.6–98.5) 803/824 97.5 (96.1–98.3) 12/13 92.3 (66.7–98.6) 788/807 97.6 (96.4–98.5)
E. coli BAL 12/12 100 (75.8–100) 826/834 99.0 (98.1–99.5) 16/17 94.1 (73.0–99.0) 817/821 99.5 (98.8–99.8)
SPU 23/24 95.8 (79.8–99.3) 787/812 96.9 (95.5–97.9) 20/22 90.9 (72.2–97.5) 771/798 96.6 (95.1–97.7)
H. influenzae BAL 10/10 100 (72.2–100) 764/836 91.4 (89.3–93.1) 25/25 100 (86.7–100) 757/813 93.1 (91.2–94.7)
SPU 16/18 88.9 (67.2–96.9) 727/818 88.9 (86.5–90.9) 30/32 93.8 (79.9–98.3) 715/788 90.7 (88.5–92.6)
K. aerogenes BAL 6/7 85.7 (48.7–97.4) 832/839 99.2 (98.3–99.6) 8/11 72.7 (43.4–90.3) 823/827 99.5 (98.8–99.8)
SPU 3/4 75.0 (30.1–95.4) 823/832 98.9 (98.0–99.4) 6/7 85.7 (48.7–97.4) 807/813 99.3 (98.4–99.7)
K. oxytoca BAL 2/2 100 (34.2–100) 835/844 98.9 (98.0–99.4) 4/7 57.1 (25.0–84.2) 824/831 99.2 (98.3–99.6)
SPU 9/9 100 (70.1–100) 817/827 98.8 (97.8–99.3) 7/8 87.5 (52.9–97.8) 801/812 98.6 (97.6–99.2)
K. pneumoniae group BAL 15/15 100 (79.6–100) 819/831 98.6 (97.5–99.2) 18/19 94.7 (75.4–99.1) 810/819 98.9 (97.9–99.4)
SPU 21/23 91.3 (73.2–97.6) 769/813 94.6 (92.8–95.9) 31/33 93.9 (80.4–98.3) 754/787 95.8 (94.2–97.0)
M. catarrhalis BAL 0/0 817/846 96.6 (95.1–97.6) 9/9 100 (70.1–100) 810/829 97.7 (96.4–98.5)
SPU 5/5 100 (56.6–100) 761/831 91.6 (89.5–93.3) 23/24 95.8 (79.8–99.3) 746/796 93.7 (91.8–95.2)
Proteus spp. BAL 5/5 100 (56.6–100) 837/841 99.5 (98.8–99.8) 5/5 100 (56.6–100) 829/833 99.5 (98.8–99.8)
SPU 15/15 100 (79.6–100) 813/821 99.0 (98.1–99.5) 6/7 85.7 (48.7–97.4) 797/813 98.0 (96.8–98.8)
P. aeruginosa BAL 36/36 100 (90.4–100) 772/810 95.3 (93.6–96.6) 49/53 92.5 (82.1–97.0) 762/785 97.1 (95.6–98.0)
SPU 103/106 97.2 (92.0–99.0) 673/730 92.2 (90.0–93.9) 115/122 94.3 (88.6–97.2) 654/698 93.7 (91.6–95.3)
S. marcescens BAL 6/6 100 (61.0–100) 834/840 99.3 (98.5–99.7) 8/8 100 (67.6–100) 826/830 99.5 (98.8–99.8)
SPU 26/27 96.3 (81.7–99.3) 782/809 96.7 (95.2–97.7) 25/29 86.2 (69.4–94.5) 763/791 96.5 (94.9–97.5)
S. aureus BAL 46/47 97.9 (88.9–99.6) 729/799 91.2 (89.1–93.0) 69/75 92.0 (83.6–96.3) 717/763 94.0 (92.1–95.4)
SPU 111/112 99.1 (95.1–99.8) 631/724 87.2 (84.5–89.4) 124/133 93.2 (87.6–96.4) 612/687 89.1 (86.5–91.2)
S. agalactiae BAL 1/1 821/845 97.2 (95.8–98.1) 5/5 100 (56.6–100) 813/833 97.6 (96.3–98.4)
SPU 9/9 100 (70.1–100) 793/827 95.9 (94.3–97.0) 10/10 100 (72.2–100) 778/810 96.0 (94.5–97.2)
S. pneumoniae BAL 5/5 100 (56.6–100) 817/841 97.1 (95.8–98.1) 12/13 92.3 (66.7–98.6) 808/825 97.9 (96.7–98.7)
SPU 16/16 100 (80.6–100) 785/820 95.7 (94.1–96.9) 10/13 76.9 (49.7–91.8) 768/807 95.2 (93.5–96.4)
S. pyogenes BAL 2/2 100 (34.2–100) 838/844 99.3 (98.5–99.7) 5/5 100 (56.6–100) 831/833 99.8 (99.1–99.9)
SPU 6/6 100 (61.0–100) 825/830 99.4 (98.6–997) 5/6 83.3 (43.6–97.0) 808/814 99.3 (98.4–99.7)
a

SPU, sputum.

b

Any result in subject medical record.